T-bet+CD8+ T cells govern anti-PD-1 responses in microsatellite-stable gastric cancers
Abstract More than 90% of advanced gastric cancers (GC) are microsatellite-stable (MSS). Compared to the high response rate of immune checkpoint inhibitors (ICI) in microsatellite-instability-high (MSI-H) GCs, only 10% of unstratified MSS GCs respond to ICIs. In this study, we apply semi-supervised...
Saved in:
| Main Authors: | Shiying Tang, Xiaofang Che, Jinyan Wang, Ce Li, Xin He, Kezuo Hou, Xiaojie Zhang, Jia Guo, Bowen Yang, Danni Li, Lili Cao, Xiujuan Qu, Zhenning Wang, Yunpeng Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-58958-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Helicobacter pylori reversing the landscape of neoadjuvant immunotherapy for microsatellite stable gastric cancer: a multicenter cohort study
by: Chengyu Hu, et al.
Published: (2025-04-01) -
Correction: Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer
Published: (2021-10-01) -
DDR1 is identified as an immunotherapy target for microsatellite stable colon cancer by CRISPR screening
by: Miaoqing Wu, et al.
Published: (2024-11-01) -
Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancer
by: Marion Thibaudin, et al.
Published: (2023-12-01) -
Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer
by: Luís Nunes, et al.
Published: (2024-11-01)